EarlyCDT®

Early cancer detection test (EarlyCDT)

EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells.

EarlyCDT Lung is the world’s most thoroughly validated blood test for the detection of lung cancer and requires only a small volume of blood which can be taken in the community setting as well as a doctor’s surgery. Shown to detect lung cancer on average four years earlier compared to current standard clinical diagnosis, EarlyCDT Lung can also provide an effective assessment of cancer risk in indeterminate pulmonary nodules (IPNs).

I work for Oncimmune because I share its ambition to make a big difference in cancer diagnostics. We always go above and beyond to turn early detection into a reality.

Leon Jackson, Programme Manager

Nottingham